Amgen Answering the $30 Billion Riddle…Lean Towards Biotech (AMGN)
Amgen was a rare earnings bright spot yesterday, and was sporting a much more biotech look than we’ve seen from the company in some time. As Amgen handily beat top and bottom-line expectations, investors are left to decide if this company trading for 11x current year estimates deserves a multiple expansion that would put it [...]
More on this topic
(What's this?)
These Biotech Stocks Are Just What the Doctor Ordered
(Investment U, 1/28/10)
“Make 66% On This Biotech Stock By May 1″ Steve Christ
(Stock Gumshoe, 12/18/09)
Small-Cap Biotech Stocks: Why This Sector Is Set for a Huge Year
(Investment U, 1/6/10)
About
Pragmatic commentary on U.S. & global investing, demographics & secular trends, and the valuation of anything worth valuing. Objective, unbiased research; We believe in minimal design, zero gimmicks, and maximum results.
Subscribe to feed
Search
Secular Trends Holdings
- Secular Trends Portfolio Real-Time Positions
- The Fuel That Fed the Subprime Meltdown (Written in September 2007)
- Performance Studies on the DJIA & Fundamental Value Stocks (11/22/08)
- Las Vegas Sands - Are They Sustainable in 2009? (Published 11/15/08)
Older Posts That Folks Seem to Like
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 Generic License.